INTERACTIONS BETWEEN CALCIUM-CHANNEL BLOCKERS AND NON-CARDIOVASCULAR DRUGS - INTERACTIONS WITH ANTICANCER DRUGS

被引:13
作者
BAEYENS, JM
机构
来源
PHARMACOLOGY & TOXICOLOGY | 1988年 / 63卷 / 01期
关键词
D O I
10.1111/j.1600-0773.1988.tb00899.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1 / 7
页数:7
相关论文
共 53 条
[1]   INTERACTIONS BETWEEN CALCIUM-CHANNEL BLOCKERS AND NON-CARDIOVASCULAR DRUGS - INTERACTIONS WITH DRUGS ACTING AT THE NEUROMUSCULAR OR THE CNS LEVEL [J].
BAEYENS, JM ;
DELPOZO, E .
PHARMACOLOGY & TOXICOLOGY, 1988, 62 (02) :59-63
[2]  
BECK WT, 1986, CANCER RES, V46, P778
[3]  
BENSON AB, 1985, CANCER TREAT REP, V69, P795
[4]   REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY [J].
BROUWER, RML ;
FOLLATH, F ;
BUHLER, FR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 :S38-S44
[5]  
CANTWELL B, 1985, BRIT J CANCER, V52, P425
[6]  
DEVITO JM, 1986, PHARMACOTHERAPY, V6, P73
[7]  
FETHERSTON CA, 1985, BRIT J CANCER, V51, P598
[8]  
FINE RL, 1984, P AM SOC CLIN ONCOL, V2, P40
[9]   EFFECT OF VERAPAMIL ON DAUNORUBICIN ACCUMULATION IN EHRLICH ASCITES TUMOR-CELLS [J].
FRICHE, E ;
SKOVSGAARD, T ;
NISSEN, NI .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (01) :35-39
[10]  
GODFRAIND T, 1986, PHARMACOL REV, V38, P321